• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    Evonik

    Kernal Partners With Lilly Gateway Labs For Vivo Cell Therapies

    BUSINESSWIRE

    Big Pharma`s `Brexit` Draws Call For Anticompetition Probe

    FIERCE PHARMA

    European Doctors Recommend Novo And Lilly Weight-Loss Drugs

    ECONOMICTIMES

    FDA Approves Guardant360® Cdx For Eli Lilly`s Inluriyo

    BUSINESSWIRE

    Lilly Cuts Mid-Stage Obesity Study Of Muscle-Sparing Antibody

    BIOSPACE

    Lilly Opens New Gateway Labs In San Diego

    FIERCE BIOTECH

    Weight-Loss Drug Ozempic To Debut In India Soon

    ECONOMICTIMES

    Lilly`s Kisunla Granted EU Approval For Early Alzheimer`s disease

    PR NEWSWIRE

    FDA Approves Inluriyo for Adults Metastatic Breast Cancer

    PR NEWSWIRE

    Eli Lilly`s Inluriyo Receives Approval in US

    FDA

    Eli Lilly To Launch Weight-Loss Pill In India, Confirms Executive

    ECONOMICTIMES

    Lilly CEO: England Unattractive For Investment

    FIERCE PHARMA

    Prellis Bio Collaborates With Lilly On Human Antibody Therapeutic

    PR NEWSWIRE

    LifeSpan Portfolio Co. Remedium Inks Landmark Deal with Eli Lilly

    PR NEWSWIRE

    Roche`s Obesity Ambition Not Reliant on One Megablockbuster

    FIERCE BIOTECH

    Eli Lilly to make weight-loss Pill in new $6.5 B Texas plant

    REUTERS

    Celltrion Unit Pays $330 M for Eli Lilly Production Facility

    REUTERS

    Innovent`s Weight-Loss Drug Highlights China Challenge for Novo

    REUTERS

    Spam Bombardment Puts Lilly in Trouble with UK Watchdog

    FIERCE PHARMA

    After Mounjaro, Eli Lilly Plans Weight loss Pill launch In India

    ECONOMICTIMES

    Novo Boosts Wegovy Pill Case Before FDA Decision

    FIERCE PHARMA

    Lilly`s Mounjaro Wins in Type 2 Diabetes Kids Trial 10-17

    FIERCE PHARMA

    Lilly`s Oral GLP-1 Orforglipron Superior to Semaglutide in Trial

    PR NEWSWIRE

    Lilly`s Mounjaro Helps Improve Blood Sugar Control in Children

    REUTERS

    Eli Lilly to Create 2,500 Jobs in Virginia with $5B Plant

    BIOSPACE

    Lilly Weight-Loss Pill Could Be FDA-Approved by Year-End

    REUTERS

    FDA Issues Over 100 Warnings in Ad Crackdown

    RAPS

    Lilly to Construct $5B Manufacturing Facility in Virginia

    REUTERS

    Eli Lilly Rethinks UK Biotech Incubator

    FIERCE BIOTECH

    Lilly Joins Bernstein`s 2nd Annual Healthcare Forum

    PR NEWSWIRE

    Eli Lilly loses appeal of $183.7 million Medicaid fraud award

    REUTERS

    Eli Lilly Enlists Julianne Moore for Brain Health Campaign

    FIERCE PHARMA

    Insitro & Lilly Collab on Machine Learning for Drug Discovery

    BUSINESSWIRE

    Novo, Lilly Obesity Drugs Deemed `Highly Cost-Effective` by ICER

    FIERCE PHARMA

    Circle Pharma & Eli Collaborate for AI-Driven Drug Discovery

    PRESS RELEASE

    Lilly and Julianne Moore Launch `Brain Health Matters` Campaign

    PR NEWSWIRE

    Alchemab Starts Phase 1 Trial of ATLX-1282, Extends Financing

    PR NEWSWIRE

    Lilly Launches AI-Powered Platform to Accelerate Drug Discovery

    PRESS RELEASE

    Lilly`s Blood Cancer Drug Meets Main Goal in Late-Stage Study

    REUTERS

    Remedium, Lilly Collaborate on Obesity, T2D Gene Therapy

    ACCESSWIRE

    WHO Includes GLP-1s in Essential Medicines List

    BIOSPACE

    Europe Warns of Surge in Illegal Obesity Drugs

    FIERCE PHARMA

    Eli Lilly Names Dr. Vivek Sr. Director of AI Commercial Strategy

    INDPHARMAPOST

    Lilly Halts Two Mid-Stage Trials for Obesity Asset

    BIOSPACE

    Lilly ends 2 midstage trials for oral GLP-1 drug naperiglipron

    FIERCE BIOTECH

    Novo`s Wegovy Cuts Heart Risk by 57% versus Rival Lilly Drug

    REUTERS

    Lilly links up with JD Health for DTC Drug Sales in China

    FIERCE PHARMA

    Lilly, AZ Home in On Sites in Virginia for New Plants

    FIERCE PHARMA

    Lilly Pauses UK Orders on Its Diabetes and Obesity Med Mounjaro

    FIERCE PHARMA

    Lilly Answers Novartis Breast Cancer Rivalry with Survival Win

    FIERCE PHARMA

    Lilly’s Verzenio Extends Survival in HR+, HER2- Breast Cancer

    PR NEWSWIRE

    Lilly Pill Cuts Weight by 10.5% in Patients with Type 2 Diabetes

    REUTERS

    Lilly, Viking Data Reset Oral Weight-Loss Race

    BIOSPACE

    Incyclix Bio Boost Funding by $11.25M for INX-315 Phase 1/2 Trial

    GLOBENEWSWIRE

    Immuneering Partners with Lilly for Atebimetinib-Olomorasib

    GLOBENEWSWIRE

    Eli Lilly to Join Morgan Stanley Global Healthcare Conference

    PR NEWSWIRE

    Lilly Joins Wells Fargo`s 20th Annual Healthcare Conference

    PR NEWSWIRE

    Trump Administration Imposes 15% Generic Drug Tariff on EU

    BIOSPACE

    Lilly`s Kisunla Excels in Initial Alzheimer`s Med Ad

    FIERCE PHARMA

    Anne White Retires as EVP and President of Lilly Neuroscience

    PR NEWSWIRE

    Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.